Canaccord Genuity Maintains Buy on Blend Labs, Lowers Price Target to $3

Blend Labs, Inc. Class A

Blend Labs, Inc. Class A

BLND

0.00

Canaccord Genuity analyst Joseph Vafi maintains Blend Labs (NYSE: BLND) with a Buy and lowers the price target from $4.5 to $3.